Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · IEX Real-Time Price · USD
5.43
-0.06 (-1.09%)
At close: Jul 2, 2024, 4:00 PM
5.48
+0.05 (0.92%)
After-hours: Jul 2, 2024, 6:18 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $776.59 million as of July 2, 2024. Its market cap has decreased by -41.18% in one year.
Market Cap
776.59M
Enterprise Value
545.22M
1-Year Change
-41.18%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $776.59M, an increase of 518.80%. That is a compound annual growth rate of 20.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 785.20M | -39.18% |
Dec 29, 2023 | 1.29B | 110.29% |
Dec 30, 2022 | 613.90M | -79.30% |
Dec 31, 2021 | 2.97B | 69.58% |
Dec 31, 2020 | 1.75B | -8.45% |
Dec 31, 2019 | 1.91B | 233.25% |
Dec 31, 2018 | 573.20M | 50.68% |
Dec 29, 2017 | 380.40M | 366.75% |
Dec 30, 2016 | 81.50M | 3.69% |
Dec 31, 2015 | 78.60M | -31.17% |
Dec 31, 2014 | 114.20M | -9.00% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ARS Pharmaceuticals | 839.11M |
Healthcare Services Group | 829.26M |
AbCellera Biologics | 814.53M |
Atrion | 797.94M |
Cogent Biosciences | 787.85M |
Viridian Therapeutics | 776.08M |
CareDx | 776.05M |
Dianthus Therapeutics | 771.01M |